Table 6.
Compound | MW a | Stock (mM) b | Test Range (µM) c | Growth Inhibition d |
---|---|---|---|---|
(10) | 222.63 | 100 | 300, 30, 3, 0.3 | No |
(11) | 257.07 | 100 | 300, 30, 3, 0.3 | No |
(12) | 206.27 | 100 | 300, 30, 3, 0.3 | Yes |
(13) | 220.30 | 100 | 300, 30, 3, 0.3 | Yes |
(14) | 224.26 | 100 | 300, 30, 3, 0.3 | Yes |
(15) | 240.72 | 100 | 300, 30, 3, 0.3 | Yes |
(16) | 240.72 | 100 | 300, 30, 3, 0.3 | Yes |
(17) | 275.16 | 100 | 30, 3, 0.3, 0.03 | No |
(18) | 248.35 | 100 | 30, 3, 0.3, 0.03 | No |
(19) | 262.37 | 100 | 30, 3, 0.3, 0.03 | No |
(20) | 195.65 | 100 | 3, 0.3, 0.03, 0.003 | No |
(21) | 181.62 | 100 | 30, 3, 0.3, 0.03 | Yes |
(22) | 245.06 | 100 | 30, 3, 0.3, 0.03 | Yes |
(23) | 190.16 | 100 | 3, 0.3, 0.03, 0.003 | No |
(24) | 315.20 | 40 | 20, 2, 0.2, 0.02 | No |
(25) | 362.25 | 25 | 7.5, 0.75, 0.075, 0.0075 | No |
(26) | 325.75 | 100 | 3, 0.3, 0.03, 0.003 | Yes |
Compound Molecular Weight in g/mol.
Stock inhibitor solutions were initially prepared in 100% DMSO to achieve a 100 mM concentration. Compounds that were insoluble at 100 mM were adjusted by addition of DMSO until solubility was achieved.
All compounds were initially tested for toxicity against uninfected ECs. Working concentration test ranges that produced no EC toxicity were selected for further testing against R. prowazekii-infected ECs.
Inhibition of rickettsial growth was determined using the in vitro host EC viability assay described in the Experimental Methods section.